Xiaotao Jiang

791 total citations
16 papers, 579 citations indexed

About

Xiaotao Jiang is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Xiaotao Jiang has authored 16 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 7 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Xiaotao Jiang's work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers) and Hepatitis B Virus Studies (5 papers). Xiaotao Jiang is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers) and Hepatitis B Virus Studies (5 papers). Xiaotao Jiang collaborates with scholars based in China, New Zealand and United Kingdom. Xiaotao Jiang's co-authors include Yongyin Li, Lei Huang, Jinlin Hou, Shiwu Ma, Jian Sun, William G.H. Abbott, Xuan Liu, Jiaxin Liang, Yixin Liu and Xu Jiang and has published in prestigious journals such as PLoS ONE, Hepatology and Journal of Hepatology.

In The Last Decade

Xiaotao Jiang

16 papers receiving 574 citations

Peers

Xiaotao Jiang

IMMUN

ONCOL

HEPAT

EPIDE

Longchao Liu United States

Hiroto Matsui Japan

Yanan Gao China

Shigeru Yutani Japan

Yusuke Muto Japan

Patrick Roelli Switzerland

Chang Gon Kim South Korea

Archana Panikkar Australia

Giovanni Nitti United States

Longchao Liu United States

Xiaotao Jiang

460 ×1.7

IMMUN

280 ×1.1

ONCOL

136 ×0.8

HEPAT

212 ×1.2

EPIDE

246 ×1.9

Citations per year, relative to Xiaotao Jiang Xiaotao Jiang (= 1×) peers Longchao Liu

Countries citing papers authored by Xiaotao Jiang

Since Specialization

Citations

This map shows the geographic impact of Xiaotao Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaotao Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaotao Jiang more than expected).

Fields of papers citing papers by Xiaotao Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaotao Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaotao Jiang. The network helps show where Xiaotao Jiang may publish in the future.

Co-authorship network of co-authors of Xiaotao Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaotao Jiang. A scholar is included among the top collaborators of Xiaotao Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaotao Jiang. Xiaotao Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Liu, Yixin, Xuan Liu, Song Xu, et al.. (2025). Novel GPC3 N-terminal bispecific antibody exhibits dual anti-tumor effect against tumor cells. Investigational New Drugs. 43(3). 588–601. 2 indexed citations

Wang, Yuanzhan, Xiaoyong Zhang, Zi‐Guo Yuan, et al.. (2024). Atg5 deficiency in macrophages protects against kidney fibrosis via the CCR6-CCL20 axis. Cell Communication and Signaling. 22(1). 223–223. 6 indexed citations

Galva, Leidy D. Caraballo, Xiaotao Jiang, Mohamed S. Hussein, et al.. (2021). Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology. 76(2). 330–344. 17 indexed citations

Liu, Xuan, et al.. (2021). Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects. Frontiers in Immunology. 12. 765101–765101. 110 indexed citations

Liu, Yixin, et al.. (2021). The immunology and immunotherapy for COVID-19. Expert Reviews in Molecular Medicine. 23. e24–e24. 3 indexed citations

Liu, Xuan, et al.. (2020). Split chimeric antigen receptor-modified T cells targeting glypican-3 suppress hepatocellular carcinoma growth with reduced cytokine release. Therapeutic Advances in Medical Oncology. 12. 3863525387–3863525387. 34 indexed citations

Chen, Chengcong, Xiaotao Jiang, Xuan Liu, et al.. (2020). Identification of the association between HBcAg-specific T cell and viral control in chronic HBV infection using a cultured ELISPOT assay. Journal of Leukocyte Biology. 109(2). 455–465. 10 indexed citations

Jiang, Xiaotao, Xu Jiang, Mingfeng Liu, et al.. (2019). Adoptive CD8+ T cell therapy against cancer:Challenges and opportunities. Cancer Letters. 462. 23–32. 101 indexed citations

Zhu, Wei, Yibing Peng, Lan Wang, et al.. (2018). Identification of α‐fetoprotein‐specific T‐cell receptors for hepatocellular carcinoma immunotherapy. Hepatology. 68(2). 574–589. 82 indexed citations

10.

Lai, Qintao, Shiwu Ma, Junwei Ge, et al.. (2014). TCRγδ+CD4−CD8− T Cells Suppress the CD8+ T-Cell Response to Hepatitis B Virus Peptides, and Are Associated with Viral Control in Chronic Hepatitis B. PLoS ONE. 9(2). e88475–e88475. 15 indexed citations

11.

Hu, Xingbin, Shiwu Ma, Xuan Huang, et al.. (2011). Interleukin‐21 is upregulated in hepatitis B‐related acute‐on‐chronic liver failure and associated with severity of liver disease. Journal of Viral Hepatitis. 18(7). 458–467. 41 indexed citations

12.

Jiang, Xiaotao, Mingxia Zhang, Qintao Lai, et al.. (2011). Restored Circulating Invariant NKT Cells Are Associated with Viral Control in Patients with Chronic Hepatitis B. PLoS ONE. 6(12). e28871–e28871. 38 indexed citations

13.

Ma, Shiwu, Xuan Huang, Libo Tang, et al.. (2011). High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. Journal of Hepatology. 56(4). 775–781. 89 indexed citations

14.

Wu, Shanyun, Ping Lei, Qiyun Yi, et al.. (2010). CC chemokine ligand 21 enhances the immunogenicity of the breast cancer cell line MCF-7 upon assistance of TLR2. Carcinogenesis. 32(3). 296–304. 23 indexed citations

15.

Jiang, Xiaotao, et al.. (2009). Production and Characterization of a Cross-Reactive Monoclonal Antibody to Lipopolysaccharide. Hybridoma. 28(2). 93–99. 3 indexed citations

16.

Xiao, Haiyan, et al.. (2009). Generation and characterization of human δ-globin-specific monoclonal antibodies. Blood Cells Molecules and Diseases. 44(3). 127–132. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact